Guizhou Sanli Pharmaceutical Co., Ltd. (603439.SH) has cumulatively repurchased shares totaling 1.23%, amounting to 61.09 million yuan.

Guizhou Sanli Pharmaceutical Co., Ltd. (603439.SH) announced that as of September 20, 2024, the company had repurchased a total of 5.0317 million shares through centralized bidding trading, accounting for 1.23% of the total share capital of the company as of the date of this announcement. The highest repurchase price was RMB 13.12 per share, and the lowest repurchase price was RMB 11.71 per share, with a total amount of funds used for repurchase of RMB 61.0931 million (excluding transaction costs).